TardiMed Sciences LLC - 28 May 2021 Form 4 Insider Report for Timber Pharmaceuticals, Inc.

Role: 10%+ Owner
Signature: /s/ Michael Derby, Managing Partner of TardiMed Sciences LLC
Issuer symbol: N/A
Transactions as of: 28 May 2021
Net transactions value: -$84,019
Form type: 4
Filing time: 02 Jun 2021, 17:57:22 UTC
Next filing: 10 Jun 2021
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	TMBR	Common Stock, par value $0.001 per share	Sale	$60,620	-47,736	-0.88%	$1.27	5,389,781	28 May 2021	Direct	F1
transaction	TMBR	Common Stock, par value $0.001 per share	Sale	$10,952	-8,670	-0.16%	$1.26	5,381,111	01 Jun 2021	Direct	F2
transaction	TMBR	Common Stock, par value $0.001 per share	Sale	$12,448	-9,879	-0.18%	$1.26	5,371,232	02 Jun 2021	Direct

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The price represents the weighted average sales price for multiple transactions reported on this line. The prices of the transactions ranged from $1.26 to $1.32, inclusive. The reporting person undertakes to provide to Timber Pharmaceuticals, Inc. ("Timber"), any security holder of Timber, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth herein.
F2	The price represents the weighted average sales price for multiple transactions reported on this line. The prices of the transactions ranged from $1.26 to $1.28, inclusive. The reporting person undertakes to provide to Timber, any security holder of Timber, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth herein.

Content

The price represents the weighted average sales price for multiple transactions reported on this line. The prices of the transactions ranged from $1.26 to $1.32, inclusive. The reporting person undertakes to provide to Timber Pharmaceuticals, Inc. ("Timber"), any security holder of Timber, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth herein.

The price represents the weighted average sales price for multiple transactions reported on this line. The prices of the transactions ranged from $1.26 to $1.28, inclusive. The reporting person undertakes to provide to Timber, any security holder of Timber, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth herein.